Nuvio company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

nuvio.com

Stage

Other Investors | Alive

About Nuvio

Nuvio is developing advanced solutions and creating simple, reliable, easy-to-use applications that allow organizations to focus on growing their business instead of managing their infrastructure .

Nuvio Headquarter Location

8500 W 110Th Street Suite 450

Overland Park, Kansas, 66210,

United States

(+8164) 444-422-5853

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Nuvio News

MicroSintesis and Bio Agri Mix Sign Exclusive Agreement to Market Game-Changing Proteobiotic Technology to Canadian Swine Producers Français

Oct 5, 2017

Distribution agreement will create opportunities to reduce antibiotic use in the future MITCHELL, ON, Oct. 5, 2017 /CNW/ - MicroSintesis and Bio Agri Mix have signed a distribution agreement to market a unique Proteobiotic technology for Canadian swine production. Nuvio is the first product made of protein sources that contain probiotic molecules, termed Proteobiotics, which have been proven in clinical trials to significantly improve producer outcomes when faced with post-weaning diarrhea challenges. Bacteria use a mechanism called Quorum Sensing that lets them communicate with each other and act as a unified group. This communication process enables bacteria to express virulence factors such as biofilm formation, adhesion, invasion and toxin release. Proteobiotics use a non-antibiotic, anti-infective mode of action that supports the gut's natural immune defences by stopping the cell-to-cell communication of these bacteria. In recent trials, the product was 86% effective at reducing clinical diarrhea symptoms with statistically significant improvements in weight gain and feed conversion during the trial period. Initially discovered at the University of Guelph, the development of the product has been a collaborative effort between MicroSintesis and the University of Guelph, and has been independently validated in clinical research studies as well as in a veterinary monitored commercial field trial. "Nuvio has the potential to be a new, first-line product in the fight against the production problems associated with post-weaning diarrhea," said Trevor Lank, Swine Technical Consultant for MicroSintesis. "It can be easily administered with other products such as vaccines or antibiotics without withdrawal periods, and because the proteobiotics work on reducing bacteria communication, no period for immunity building is required. The proteobiotics simultaneously reduce the pathogenic bacteria's effectiveness while increasing the ratio of the natural gut flora. It is truly an all-in-one technology." Dr. Robert Bell, CEO of Bio Agri Mix, added, "Over my forty-year career in the animal health industry, I have witnessed the launch of a handful of revolutionary technologies; endectocides, prostaglandins and long-lasting time dependent antimicrobials, and there is no doubt Nuvio is in the same league with these game-changing products, particularly when the animal health industry is tasked with ensuring prudent antimicrobial use and reduced antimicrobial resistance. Nuvio has been proven to be clinically effective in conventional swine systems and will fill a unique void for "raised without antimicrobial" swine production." "MicroSintesis is delighted to have partnered with Bio Agri Mix on the commercialization of this technology. Bio Agri Mix has a proven track record not only in marketing water solubles, but has a strong commitment to leading the way through the changing antimicrobial-use regulations," said Hannah McIver, CEO of MicroSintesis. Nuvio is administered in the drinking water for the first 14 days post-weaning. It will be available through veterinarians and feed companies beginning October 2017. About MicroSintesis Founded in 2011, MicroSintesis is a Canadian life sciences company focused on creating novel anti-infectives. By harnessing the natural defense mechanisms of probiotics, MicroSintesis is on the forefront of new bio-technologies that fight antibiotic resistant bacteria and reduce the virulence of pathogens: an animal health company pioneering gut health through proteobiotics. MicroSintesis has developed a unique technology to reduce antibiotic use and create a first line of defense in the fight against antibiotic resistance bacteria. MicroSintesis manufactures to the highest standard of quality assurance, resulting in products that are simple, natural, well-defined, and supported by clinical assays, for deliverable success. About Bio Agri Mix Proudly Canadian owned and operated, Bio Agri Mix LP is Canada's largest manufacturer and distributor of medicated feed additives and water soluble medications. For more than 30 years, the company has supplied feedmills and producers with the quality products they need to improve animal health. Today Bio Agri Mix offers the largest range of products in the industry, including: Feed Medications; Disinfectants; Water Solubles; Feed Enzymes; and Anthelmintics & Parasiticides. The company's signature granulation technique allows feedmills and producers to more accurately dose livestock. Bio Agri Mix is Health Canada, FDA, ISO 9001 and HACCP certified. SOURCE MicroSintesis For further information: Media Contacts: Bernice Couto, smak, 416-527-5312, bernice@smak.ca; Emily Jenniskens, ON Communication, 519-434-1365 ext. 264, emily@onocmmunication.ca Organization Profile

Nuvio Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Nuvio Rank

  • Where is Nuvio's headquarters?

    Nuvio's headquarters is located at 8500 W 110Th Street, Overland Park.

  • What is Nuvio's latest funding round?

    Nuvio's latest funding round is Other Investors.

  • Who are the investors of Nuvio?

    Investors of Nuvio include Practo Technologies, Focus Softnet, Mumbai Angels and Inventus Capital Partners.

  • Who are Nuvio's competitors?

    Competitors of Nuvio include Fuze.

You May Also Like

ShoreTel Logo
ShoreTel

ShoreTel is a provider of Unified Communication (UC) solutions based on its IP business phone system. The company offers organizations integrated, voice, video, data, and mobile communications on an open, distributed IP architecture that helps reduce complexity and costs.

SendHub Logo
SendHub

SendHub, developed by InfoReach, makes business communication fast and simple, on any device. The company's all-in-one phone system provides SMS, voice, file and conference call functionality in an easy to use mobile app. Businesses can instantly set up an entire communication system that is fully scalable, with no hardware or contract required. SendHub is headquartered in Menlo Park, CA.

Fuze Logo
Fuze

Fuze is a global, cloud-based unified communications platform that empowers productivity and delivers insights across the enterprise by enabling simplified business voice communications, flexible video conferencing and always-on collaboration. It features calling, meetings, and a contact center. Users can share content on calls and have HD audio.On December 1st, 2021, Fuze was acquired by 8x8 at a valuation of $250M.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.